160 related articles for article (PubMed ID: 22208968)
21. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
22. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
23. The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation?
Jones AS; Fish B; Fenton JE; Husband DJ
Head Neck; 2004 Feb; 26(2):127-35. PubMed ID: 14762881
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of beta1 integrin expression as a prediction marker for radiotherapy in early glottic carcinoma.
Choi SH; Cho KJ; Nam SY; Lee SW; Kang J; Kim SY
Laryngoscope; 2006 Jul; 116(7):1228-31. PubMed ID: 16826065
[TBL] [Abstract][Full Text] [Related]
25. p53 overexpression on the resection margins as a marker of local recurrence in glottic T1a carcinoma.
Allegra E; Puzzo L; Cutrona D; Trichini A; Garozzo A; Serra A
Acta Otorhinolaryngol Ital; 2003 Dec; 23(6):454-8. PubMed ID: 15198048
[TBL] [Abstract][Full Text] [Related]
26. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
[TBL] [Abstract][Full Text] [Related]
27. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
Sackett MK; Bairati I; Meyer F; Jobin E; Lussier S; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B
Clin Cancer Res; 2008 Jan; 14(1):67-73. PubMed ID: 18172254
[TBL] [Abstract][Full Text] [Related]
29. [Radiotherapy in glottic T1 carcinoma. Local control and survival].
Herranz J; Fernández M; Ramos S; Vázquez Barro C; Sarandeses García A; Martínez Vidal J; Veiras C
Acta Otorrinolaringol Esp; 2000; 51(1):57-61. PubMed ID: 10799934
[TBL] [Abstract][Full Text] [Related]
30. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.
Schrijvers ML; van Riel EL; Langendijk JA; Dikkers FG; Schuuring E; van der Wal JE; van der Laan BF
Head Neck; 2009 Jun; 31(6):759-64. PubMed ID: 19260127
[TBL] [Abstract][Full Text] [Related]
31. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma.
Lo SM; Venkatesan V; Matthews TW; Rogers J
J Otolaryngol; 1998 Oct; 27(5):247-51. PubMed ID: 9800621
[TBL] [Abstract][Full Text] [Related]
32. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
[TBL] [Abstract][Full Text] [Related]
33. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.
Chera BS; Amdur RJ; Morris CG; Kirwan JM; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):461-6. PubMed ID: 20153124
[TBL] [Abstract][Full Text] [Related]
34. Radiation therapy for management of t1-t2 glottic cancer at a private practice.
Jones DA; Mendenhall CM; Kirwan J; Morris CG; Donnan A; Holwerda S; Kraus ST; Mann CJ; Grant JR; Donnan B; Mendenhall WM
Am J Clin Oncol; 2010 Dec; 33(6):587-90. PubMed ID: 20051812
[TBL] [Abstract][Full Text] [Related]
35. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
[TBL] [Abstract][Full Text] [Related]
36. T1 glottic carcinoma involving the posterior commissure.
Shvero J; Shvili I; Mizrachi A; Shpitzer T; Nageris B; Koren R; Hadar T
Laryngoscope; 2009 Jun; 119(6):1116-9. PubMed ID: 19308987
[TBL] [Abstract][Full Text] [Related]
37. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.
Reddy SP; Hong RL; Nagda S; Emami B
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1389-94. PubMed ID: 17869013
[TBL] [Abstract][Full Text] [Related]
38. MR imaging predictors of local control of glottic squamous cell carcinoma treated with radiation alone.
Ljumanovic R; Langendijk JA; van Wattingen M; Schenk B; Knol DL; Leemans CR; Castelijns JA
Radiology; 2007 Jul; 244(1):205-12. PubMed ID: 17581903
[TBL] [Abstract][Full Text] [Related]
39. Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus.
Rabbani A; Amdur RJ; Mancuso AA; Werning JW; Kirwan J; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):351-5. PubMed ID: 18395359
[TBL] [Abstract][Full Text] [Related]
40. Ki-67 expression predicts radiotherapy failure in early glottic cancer.
Nichols AC; Whelan F; Basmaji J; Dhaliwal S; Dowthwaite S; Chapeskie C; Read N; Palma DA; Fung K; Venkatesan V; Hammond JA; Franklin JH; Siddiqui I; Wehrli B; Kwan K; Koropatnick J; Mymryk JS; Barrett JW; Yoo J
J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):124-30. PubMed ID: 22569013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
